!!Rosalind Smyth - Selected Publications
\\
1. Hawcutt DB, Fanceis B, Carr DF, Jorgensen AL, Yin P, Wallin N, O’Hara N, Zhang EJ, Bloch KM, Ganguli A, Thompson B, McEvoy L, Peak M, Crawford AA, Walker BR, Blair JC, Couriel J, Smyth RL, Pirmohamed M.  Genome-wide association study of susceptibility to corticosteroid-induced adrenal suppression. Lancet Respiratory Medicine 2018 [http://dx.doi.org/10.1016/S2213-2600(18)30058-4]\\
\\
2. Taylor-Robinson DC, Whitehead M, Diggle PJ, Smyth RL. The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study. Lancet Respiratory Medicine. 2013; 1(2) 121-128.(63 citations)\\
\\
3. Thiesen S, Conroy EJ, Bellis JR, Bracken LE, Mannix HL, Bird KA, Duncan JC, Cresswell L, Kirkham JJ, Peak M, Williamson PR, Nunn AJ, Turner MA, Pirmohamed M, Smyth RL. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions. BMC Med. 2013;11:237. (22 citations)\\
\\
4. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding DA, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smyth C, Dunning J, Gordon S, The GenISIS, The MOSAIC Investigators, Smyth RL, Openshaw P, Dougan G, Brass AL, Kellam P. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012; 484: 519-523. (299 citations)\\
\\
5.Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: Recommendations for the future based on a systematic review of existing studies. PLoS Medicine. 2011;8(1). (184 citations)\\
\\
6. Gladstone M, Lancaster GA, Umar E, Nyirenda M, Kayira E, van den Broek N, Smyth RL.  The Malawi Developmental Assessment Tool (MDAT): A validated and reliable tool for assessment of child development in rural African settings. PLoS Med 2010; 7(5): e1000273. (44 citations)\\
\\
7. McNamara PS, Flanagan BF, Baldwin LM, Newland P, Hart CA, Smyth RL. Interleukin-9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet 2004; 363(9414): 1031 – 1037. (69 citations)\\
\\
8. Craig JV, Lancaster GA, Taylor S, Williamson PR, Smyth RL.Infrared ear thermometry compared with rectal thermometry in children: a systematic review. Lancet 2002;360:603-9. (135 citations)\\
\\
9. Cheng K, Smyth RL, Govan JRW, Doherty C, Winstanley C, Denning N, Heaf DP, van Saene H, Hart CA.  Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.  Lancet 1996; 346: 639-642. (275 citations)\\
\\
10. Smyth RL, Ashby D, O’Hea U, Burrows E, Lewis PA, van Velzen D, Dodge JA.  Fibrosing colonopathy in cystic fibrosis: results of a case-control study.  Lancet 1995 346: 1247-1251. (105 citations)